Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
An open label, randomized, two-way crossover scintigraphic phase II trial to investigate lung deposition of radiolabelled OligoG CF-5/20 delivered as a dry powder and as a nebulised solution in Cystic fibrosis (CF) patients
Primary outcome measures:
To qualitatively determine the deposition of radiolabelled OligoG in the lung.
No published results found as of August 2025
…